Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical study is to investigate the efficacy and safety of Dysport® in
patients with early onset of upper limb spasticity within 2-12 weeks after stroke.
Phase:
Phase 4
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA